Back
CVD Equipment 10K Form
Sell
34
CVV
CVD Equipment
Last Price:
2.91
Seasonality Move:
20.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-13 | 10Q | CVV/CVD Equipment Quarterly |
2023-11-14 | 10Q | CVV/CVD Equipment Quarterly |
2023-08-14 | 10Q | CVV/CVD Equipment Quarterly |
2023-05-15 | 10Q | CVV/CVD Equipment Quarterly |
2022-11-14 | 10Q | CVV/CVD Equipment Quarterly |
2022-08-15 | 10Q | CVV/CVD Equipment Quarterly |
Receive CVV News And Ratings
See the #1 stock for the next 7 days that we like better than CVV
CVV Financial Statistics
Sales & Book Value
Annual Sales: | $24.11M |
---|---|
Cash Flow: | $-1.84M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.59 |
Price / Book: | 0.83 |
Profitability
EPS (TTM): | -0.78000 |
---|---|
Net Income (TTM): | $-5.26M |
Gross Margin: | $5.07M |
Return on Equity: | -19.83% |
Return on Assets: | -14.75% |
CVD Equipment Earnings Forecast
Key CVD Equipment Financial Ratios
- The Gross Profit Margin over the past 28 years for CVV is 21.03%.
- The Selling, General & Administrative Expenses for CVV have been equal to 29.38% of Gross Profit Margin.
- The Research & Development expenses have been 10.77% of Revenue.
- The Interest Expense is -0.55% of Operating Income.
- The Net Earning history of CVV is -17.34% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 12 years.
CVD Equipment Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Semiconductors & Semiconductor Equipment |
Sector: | Information Technology |
Current Symbol: | CVV |
CUSIP: | 126601 |
Website: | cvdequipment.com |
Debt
Debt-to-Equity Ratio: | 0.01 |
---|---|
Current Ratio: | 2.39 |
Quick Ratio: | 1.81 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CVV Technical Analysis vs Fundamental Analysis
Sell
34
CVD Equipment (CVV)
is a Sell
Is CVD Equipment a Buy or a Sell?
-
CVD Equipment stock is rated a Sell
The current CVD Equipment [CVV] share price is $2.95. The Score for CVV is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.